Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association.
http://ift.tt/1m6yRXO
http://ift.tt/1m6yRXO
No comments:
Post a Comment